Completed PHASE3 INTERVENTIONAL NCT00450112

Gel-200 Extension and Open-Label Study in Osteoarthritis of the Knee

A Multi-Center Extension and Open-Label Study of a Single or Repeat Intra-Articular Injection of Gel-200 in Osteoarthritis of the Knee.

Sponsor: Seikagaku Corporation

Conditions Osteoarthritis of the Knee

Interventions Gel-200

Updated 6 times since 2017 Last updated: Jul 25, 2011 Started: Mar 31, 2007 Primary completion: Jun 30, 2009 Completion: Jun 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Osteoarthritis of the Knee, this trial is completed. The trial is conducted by Seikagaku Corporation and has accumulated 6 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Seikagaku Corporation

Data source: Seikagaku Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Plantation, United States